No, following EFS we have a larger trial to go prior to FDA approval.
I imagine we'll be getting an announcement soon re financing. Tight financing is the Admedus/Anteris way. Sigh.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-17
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$6.00 |
Change
-0.120(1.96%) |
Mkt cap ! $94.23M | |||
| Open | High | Low | Value | Volume |
| $6.01 | $6.08 | $6.00 | $14.54K | 2.421K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1019 | $6.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.07 | 190 | 1 |
View Market Depth
| Last trade - 12.24pm 26/06/2025 (20 minute delay) ? |
| AVR (ASX) Chart |